• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes.

作者信息

Bjorkman P J, Strominger J L, Wiley D C

出版信息

J Mol Biol. 1985 Nov 5;186(1):205-10. doi: 10.1016/0022-2836(85)90271-2.

DOI:10.1016/0022-2836(85)90271-2
PMID:3878413
Abstract

The human histocompatibility antigens HLA-A and HLA-B are polymorphic cell surface glycoproteins encoded by the major histocompatibility complex. These molecules are the major targets for the immune response during tissue transplantation. They are recognized by cytolytic T-lymphocytes during the immune response against virally infected cells, and have been linked to variations in susceptibility to human autoaggressive and neoplastic diseases. To permit a description of the sites of interaction with alloantisera and T-cell receptors, we have begun a three-dimensional structure determination of HLA-A. We report the isomorphous cyrstallization of two antigenic specificities of papain-solubilized HLA-A, A2 and A28. Isoelectric focusing indicates that the well-ordered crystals incorporate the sialic acid microheterogeneity of the oligosaccharides. Crystallographic evidence indicates that the HLA-A molecule has an approximate 2-fold rotational symmetry axis which, combined with biochemical data, suggests that the domains of the molecule are paired alpha 1 to alpha 2 and alpha 3 to beta 2-microglobulin. This domain organization is similar to the arrangement of domains in the Fab and Fc fragments of immunoglobulins.

摘要

相似文献

1
Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes.
J Mol Biol. 1985 Nov 5;186(1):205-10. doi: 10.1016/0022-2836(85)90271-2.
2
A monoclonal antibody recognizing a determinant shared by HLA-A2 and HLA-Aw69 (A28* variant).一种识别HLA - A2和HLA - Aw69(A28 *变体)共有的决定簇的单克隆抗体。
Tissue Antigens. 1985 Aug;26(2):114-20. doi: 10.1111/j.1399-0039.1985.tb00943.x.
3
HLA antigens: rabbit antisera reacting with all A series or all B series specificities.人类白细胞抗原(HLA)抗原:与所有A系列或所有B系列特异性发生反应的兔抗血清。
Eur J Immunol. 1976 Feb;6(2):82-8. doi: 10.1002/eji.1830060203.
4
Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.交叉反应性人类组织相容性抗原HLA - A28和HLA - A2的结构:对HLA多态性产生的可能影响
Proc Natl Acad Sci U S A. 1982 Jun;79(12):3813-7. doi: 10.1073/pnas.79.12.3813.
5
Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.抗原特异性细胞毒性T淋巴细胞对种间杂交I类组织相容性抗原的识别。
Proc Natl Acad Sci U S A. 1985 Sep;82(18):6276-80. doi: 10.1073/pnas.82.18.6276.
6
Molecular characterization of HLA-A28*, a novel HLA product, and its relationship to HLA-A28 and HLA-A2.
Immunogenetics. 1984;20(2):103-15. doi: 10.1007/BF00364482.
7
The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.单克隆抗体与细胞表面分子的结合。针对人类移植抗原HLA - A2的两个同种异体抗原决定簇的免疫球蛋白G定量分析。
Biochem J. 1983 Nov 15;216(2):423-32. doi: 10.1042/bj2160423.
8
Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.HLA错配的差异免疫原性:HLA - A2与HLA - A28
Transplantation. 2003 Feb 15;75(3):418-20. doi: 10.1097/01.TP.0000044456.51462.E2.
9
Function and polymorphism of human leukocyte antigen-A,B,C molecules.人类白细胞抗原A、B、C分子的功能与多态性
Am J Med. 1988 Dec 23;85(6A):2-5. doi: 10.1016/0002-9343(88)90369-5.
10
Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro.体外通过MHC限制性肽使HLA - A2重链与β2 -微球蛋白复性。
Nature. 1991 Apr 18;350(6319):619-22. doi: 10.1038/350619a0.

引用本文的文献

1
Replacements at Structural or Functional Dimorphisms 103, 109 and 167 Distinguish HLA Class I Serologically Defined Antigens.结构或功能二态性处的替换103、109和167区分了血清学定义的HLA I类抗原。
HLA. 2025 Sep;106(3):e70387. doi: 10.1111/tan.70387.
2
Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First.MHC 类 I 和类 II 之间的结构比较;在进化过程中,可能首先出现了一种类 II 样分子。
Front Immunol. 2021 Jun 14;12:621153. doi: 10.3389/fimmu.2021.621153. eCollection 2021.
3
The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling.
分子灵活性在抗原呈递和T细胞受体介导信号传导中的作用
Front Immunol. 2018 Jul 17;9:1657. doi: 10.3389/fimmu.2018.01657. eCollection 2018.
4
Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice.用木瓜蛋白酶预处理供体胰岛可提高小鼠同种异体移植存活率,且无需全身免疫抑制。
Islets. 2016 Sep 2;8(5):145-55. doi: 10.1080/19382014.2016.1223579.
5
T cells and their eons-old obsession with MHC.T 细胞及其对 MHC 的千年痴迷。
Immunol Rev. 2012 Nov;250(1):49-60. doi: 10.1111/imr.12004.
6
Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.采用随机森林方法鉴定与无关供者造血细胞移植后第 100 天生存率降低相关的 HLA I 类氨基酸取代。
Bone Marrow Transplant. 2012 Feb;47(2):217-26. doi: 10.1038/bmt.2011.56. Epub 2011 Mar 28.
7
The Goldilocks model for TCR-too much attraction might not be best for vaccine design.TCR 亲和力过高可能并不适合疫苗设计的金发姑娘模型。
PLoS Biol. 2010 Sep 14;8(9):e1000482. doi: 10.1371/journal.pbio.1000482.
8
Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db.β2-微球蛋白对于小鼠I类组织相容性抗原H-2Db或截短的H-2Db的细胞表面表达不是必需的。
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7447-51. doi: 10.1073/pnas.83.19.7447.
9
Analysis of structure/function relationships among major histocompatibility complex class I antigens.主要组织相容性复合体I类抗原的结构/功能关系分析
Immunol Res. 1987;6(1-2):67-79. doi: 10.1007/BF02918105.
10
Engineering soluble major histocompatibility molecules: why and how.工程化可溶性主要组织相容性分子:原因与方法
Immunol Res. 1987;6(1-2):101-16. doi: 10.1007/BF02918107.